FR2600895B1 - Utilisation de l'activateur tissulaire du plasminogene, son association avec une superoxyde-dismutase et formulation pharmaceutique contenant cette association - Google Patents

Utilisation de l'activateur tissulaire du plasminogene, son association avec une superoxyde-dismutase et formulation pharmaceutique contenant cette association

Info

Publication number
FR2600895B1
FR2600895B1 FR8706551A FR8706551A FR2600895B1 FR 2600895 B1 FR2600895 B1 FR 2600895B1 FR 8706551 A FR8706551 A FR 8706551A FR 8706551 A FR8706551 A FR 8706551A FR 2600895 B1 FR2600895 B1 FR 2600895B1
Authority
FR
France
Prior art keywords
association
dismutase
superoxide
pharmaceutical formulation
formulation containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8706551A
Other languages
English (en)
Other versions
FR2600895A1 (fr
Inventor
Jr Et Crist John Frangakis Henry Berger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/862,057 external-priority patent/US4976959A/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2600895A1 publication Critical patent/FR2600895A1/fr
Application granted granted Critical
Publication of FR2600895B1 publication Critical patent/FR2600895B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21068—Tissue plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR8706551A 1986-05-12 1987-05-11 Utilisation de l'activateur tissulaire du plasminogene, son association avec une superoxyde-dismutase et formulation pharmaceutique contenant cette association Expired - Lifetime FR2600895B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86204686A 1986-05-12 1986-05-12
US06/862,057 US4976959A (en) 1986-05-12 1986-05-12 T-PA and SOD in limiting tissue damage

Publications (2)

Publication Number Publication Date
FR2600895A1 FR2600895A1 (fr) 1988-01-08
FR2600895B1 true FR2600895B1 (fr) 1993-12-24

Family

ID=27127662

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8706551A Expired - Lifetime FR2600895B1 (fr) 1986-05-12 1987-05-11 Utilisation de l'activateur tissulaire du plasminogene, son association avec une superoxyde-dismutase et formulation pharmaceutique contenant cette association

Country Status (13)

Country Link
JP (1) JPH0680015B2 (fr)
AU (1) AU600724B2 (fr)
BE (1) BE1001425A4 (fr)
CH (1) CH672989A5 (fr)
DE (1) DE3715662A1 (fr)
DK (1) DK237187A (fr)
FR (1) FR2600895B1 (fr)
GB (1) GB2194886B (fr)
IE (1) IE59895B1 (fr)
LU (1) LU86875A1 (fr)
NL (1) NL8701113A (fr)
NZ (1) NZ220260A (fr)
SE (1) SE8701921L (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0780784B2 (ja) * 1987-10-23 1995-08-30 宇部興産株式会社 微小循環障害に基づく心筋虚血傷害治療薬
NZ230808A (en) * 1988-10-24 1993-04-28 Squibb & Sons Inc Pharmaceutical compositions and combinations containing an angiotensin-converting enzyme inhibitor and a thrombolytic agent
DE4038563A1 (de) * 1990-12-04 1992-06-11 Gruenenthal Gmbh Verwendung von superoxiddismutasen zur prophylaxe und/oder behandlung von organversagen bei risikopatienten mit polytrauma
DE19518625C2 (de) * 1995-05-24 1997-08-07 Buescher Pebueso Beton Verfahren zum Abdichten von Betonrohren und ein für die Durchführung des Verfahrens geeignetes Betonrohr
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US6921751B1 (en) 1998-05-20 2005-07-26 Erasmus Universiteit Rotterdam Immunoregulator
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US7175679B2 (en) 2001-03-29 2007-02-13 Biotempt B.V. Oligopeptide treatment of NF-κB mediated inflammation
EP1138692A1 (fr) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragments de gonadotrophine chorionique humaine comme immunorégulateurs
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
EP1300418A1 (fr) 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Régulation génétique par des oligopeptides
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
US7576174B2 (en) 2000-03-29 2009-08-18 Biotempt B.V. Compositions capable of reducing elevated blood urea concentration
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
US7786084B2 (en) 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US7501391B2 (en) 2001-12-21 2009-03-10 Biotempt B.V. Treatment of transplant survival
US7517529B2 (en) 2003-04-08 2009-04-14 Biotempt B.V. Treatment of type I diabetes
SG163567A1 (en) 2005-07-05 2010-08-30 Biotempt Bv Treatment of tumors
EP1864692A1 (fr) 2006-06-07 2007-12-12 Biotempt B.V. Utilisation de peptides pour la protection contre les radiolésions
WO2011013668A1 (fr) * 2009-07-27 2011-02-03 国立大学法人新潟大学 Composition pharmaceutique utilisable dans le cadre du traitement d'événements ischémiques
US8652476B2 (en) 2009-07-27 2014-02-18 Niigata University Pharmaceutical composition for treating ischemic events

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8003402A (nl) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
EP0112122B1 (fr) * 1982-12-14 1991-08-28 South African Inventions Development Corporation Activateur de plasminogène
JPS59196824A (ja) * 1983-04-21 1984-11-08 Kowa Co 吸着防止剤
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
ES8706443A1 (es) * 1985-05-28 1987-07-01 Wellcome Found Un procedimiento para preparar una solucion parenteral de activador de plasminogeno de tejido (t-pa)
AU6334586A (en) * 1986-05-15 1987-12-01 Emory University Composition and method for treating a thrombus and embolus

Also Published As

Publication number Publication date
GB2194886A (en) 1988-03-23
GB2194886B (en) 1990-04-25
DK237187A (da) 1987-11-13
IE59895B1 (en) 1994-04-20
CH672989A5 (fr) 1990-01-31
FR2600895A1 (fr) 1988-01-08
AU600724B2 (en) 1990-08-23
DE3715662A1 (de) 1987-11-19
AU7270487A (en) 1987-11-19
JPH0680015B2 (ja) 1994-10-12
GB8711058D0 (en) 1987-06-17
JPS6322026A (ja) 1988-01-29
IE871210L (en) 1987-11-12
NZ220260A (en) 1990-07-26
NL8701113A (nl) 1987-12-01
LU86875A1 (fr) 1988-01-20
DK237187D0 (da) 1987-05-11
SE8701921D0 (sv) 1987-05-11
SE8701921L (sv) 1987-11-13
BE1001425A4 (fr) 1989-10-31

Similar Documents

Publication Publication Date Title
FR2600895B1 (fr) Utilisation de l'activateur tissulaire du plasminogene, son association avec une superoxyde-dismutase et formulation pharmaceutique contenant cette association
DE69414114D1 (de) Kalt-sterilisermittel mit verlängerter aktivät
IL89276A0 (en) Human relaxin formulation
ES2044718T3 (es) Preparacion que contiene enzimas y detergente que contiene dicha preparacion.
ATE91901T1 (de) Vehikel zur verabreichung von interferon.
SE8903914D0 (sv) Oral composition for the treatment of inflammatory bowel diseases
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
JPS6236502B2 (fr)
SE9203818D0 (sv) Maskindiskmedel och dess anvaendning
Summaria et al. The Active Site of Bovine Plasminogen Activator: INTERACTION OF STREPTOKINASE WITH HUMAN PLASMINOGEN AND PLASMIN
KR900002802A (ko) 면역억제제로서의 트랜스글루타미나제의 용도
JPS5587712A (en) Skin cosmetic
ES2013500A6 (es) Metodo para producir una variante de secuencioa de aminoacidos de un activador de plasmionogeno.
KR900702018A (ko) 단백질과 핵산
ES2000033A6 (es) Composicion de bitionol sulfoxido porcedimiento para su fabricacion y metodo de utilizacion de aquella
ATE103178T1 (de) T-pa pro stabilisierung.
HUP0100479A2 (hu) Speciális felülettel rendelkező mosogatószer-formatest
ATE56147T1 (de) T-pa enthaltende medizinische zubereitung und deren verwendung.
ATE128358T1 (de) Therapeutische mittel für diabetisches gangrän.
EP0386240A4 (en) Novel polypeptide compounds
SU1517173A1 (ru) Антисептическое средство
Hoang et al. Gas gangrene: A therapeutic update.
SUGIURA et al. Determination of Trypsin Activity in Serum
Maslov et al. Anti-inflammatory properties of asperase--a new enzymatic substance with proteolytic action
SU1828577A3 (ru) Состав, стимулирующий лейкопоэз

Legal Events

Date Code Title Description
TP Transmission of property